U.S. Mortgage Finance Stock News

In late May 2026, Penguin Solutions, Inc. announced that Chief Financial Officer and Senior Vice President Nate Olmstead will resign effective July 8, 2026, with Vice President of Finance and Accounting Aaron Johnson stepping in as interim CFO and principal financial and accounting officer from July 9, 2026. At the same time, Penguin reaffirmed its fiscal 2026 guidance and now expects net sales and diluted EPS to land at the top of prior ranges, citing very strong agentic AI-driven demand...

Pegasystems recently used its PegaWorld conference to unveil Pega Infinity 26, a suite of AI-powered upgrades spanning development, customer engagement, pricing, and mainframe modernization, including the new Pega Infinity Studio and Customer Engagement Studio. The company is positioning its “Predictable AI” architecture and expanded AWS integration as a way for enterprises to scale agentic AI with stronger governance and more controllable costs, while also investing in free training to...

UGI (UGI) is in the middle of a broad reshaping of its business, from selling its electric division and building out natural gas infrastructure to expanding online propane sales and delivering on early ESG commitments. See our latest analysis for UGI. Recent moves like the electric division sale, new gas infrastructure projects in Pennsylvania and online AmeriGas propane sales have come alongside a 1 month share price return of about 7%, while the year to date share price is still down around...

Braze (BRZE) stock came into focus after first quarter results showed sales of US$211 million, a smaller net loss, and guidance for higher revenue, even though the shares fell following the report. See our latest analysis for Braze. At a share price of US$23.07, Braze has seen a 23.43% 90 day share price return but is down 29.12% year to date, with a 1 year total shareholder return that declined 24.73%. This suggests recent momentum has firmed up following a weaker stretch. If you are looking...

Bread Financial Holdings (BFH) has drawn investor attention after recent share price gains coincided with fresh performance metrics, including revenue of US$2.64b and net income of US$558 million for its tech-focused lending and payment services. See our latest analysis for Bread Financial Holdings. At a latest share price of US$91.42, Bread Financial Holdings has seen a 90 day share price return of 25.94% and a 1 year total shareholder return of 80.81%, which indicates that momentum has been...

In the past, several law firms, including Levi & Korsinsky, Rosen Law Firm and Holzer & Holzer, announced securities class action lawsuits against Regencell Bioscience Holdings after the company disclosed a Department of Justice subpoena into trading of its ordinary shares. The cases focus on allegations that Regencell issued materially false or misleading statements and failed to disclose its vulnerability to market manipulation during the October 28, 2024 to October 31, 2025 period...

Jacobs Solutions: recent returns and business mix Jacobs Solutions (J) has drawn investor attention after a period of mixed share performance, with short term returns soft yet longer multiyear figures remaining positive. This has prompted closer focus on how its global consulting and infrastructure operations stack up. See our latest analysis for Jacobs Solutions. At a share price of US$119.96, Jacobs Solutions has seen its short term momentum soften, with the share price return declining...

Why Avnet Stock Is On Investors’ Radar Avnet (AVT) has drawn fresh attention after recent gains, with the stock closing at US$87.05 and posting solid total returns over the past year, the past 3 months, and the past month. See our latest analysis for Avnet. The recent move to US$87.05 comes after a strong run, with a 30 day share price return of 6.04% and a 1 year total shareholder return of 72.78%. This points to momentum that investors are still watching closely. If Avnet’s run has you...

Recent performance snapshot for StoneCo (NasdaqGS:STNE) StoneCo (NasdaqGS:STNE) has drawn fresh attention after a period of mixed share performance, with the stock up 1.6% over the past day but down over the past week, month, past 3 months, and year to date. In this context, investors are weighing StoneCo’s current share price of $10.57, its recent annual revenue of R$13,535.522 and net income of R$3,625.311, along with a mid-range value score of 5 and an intrinsic discount estimate of...

Recent share performance context Novo Nordisk (NYSE:NVO) has been on many investors’ radar after a period of mixed share performance, with the stock down over the past month but higher over the past 3 months. At a last close of US$41.02, the stock is also lower over the year to date and the past year, while the 5 year total return remains positive. This gives investors a wide range of recent return experiences to consider. See our latest analysis for Novo Nordisk. Short term momentum has...

Investors may be wondering whether Rexford Industrial Realty is starting to look attractively priced, or if the current share price still leaves little room for upside. The stock closed at US$33.96 and has been under pressure recently, with the share price down 2.1% over the past week, 6.4% over the past month, 13.0% year to date and 2.8% over the last year. This extends a 25.2% decline over three years and 33.0% over five years. Recent coverage has focused on how industrial real estate...

Celldex Therapeutics overview and recent stock context Celldex Therapeutics (CLDX) has drawn investor attention after recent trading, with the stock closing at US$28.56. Short term moves included a 0.2% decline over the past day and a 5.2% pullback over the past week. See our latest analysis for Celldex Therapeutics. The recent pullback, including a 16% decline in the 1 month share price return, sits against a stronger backdrop, with a 1 year total shareholder return of 37.9% but weaker 3 and...

Disc Medicine recently reported updated Phase 2 RALLY-MF data showing that its investigational drug DISC-0974 produced meaningful improvements in anemia outcomes for myelofibrosis patients, while also launching a U.S. expanded access program for bitopertin in erythropoietic and X-linked protoporphyria. At the same time, the company is facing an FDA Complete Response Letter on bitopertin and a related shareholder investigation alleging potentially misleading disclosures, raising questions...

On June 1, 2026, a shareholder of New York Times (NYT), the National Center for Public Policy Research, formally demanded access to internal records after a Nicholas Kristof column sparked criticism and legal threats. See our latest analysis for New York Times. The recent activist pressure arrives after a softer near term patch for the stock, with the share price down 6.8% over the past 30 days and 6.1% over 90 days, yet backed by a 34.6% 1 year total shareholder return and a 106.3% 3 year...

Why the BoxX-NoAF trial update matters for AtriCure stock AtriCure (ATRC) has drawn fresh attention after announcing that its pivotal BoxX-NoAF clinical trial will complete patient enrollment 12 months earlier than planned, raising questions about what earlier data could mean for the stock. See our latest analysis for AtriCure. The BoxX-NoAF update has arrived at a time when AtriCure’s share price has fallen 31.46% year to date and its 1 year total shareholder return is down 21.26%, pointing...

Grand Canyon Education recently disclosed that it is in discussions with Grand Canyon University to amend their Master Services Agreement, potentially extending the partnership by eight years and revising how service fees are calculated. This contract review matters because it could reshape Grand Canyon Education’s revenue mix, concentration risk, and long-term reliance on its largest university partner. We’ll now examine how the potential eight-year extension of the Grand Canyon University...

In May 2026, Tandem Diabetes Care filed a US$47.40 million shelf registration for 3,260,000 common shares linked to its employee stock ownership plan and separately secured CE mark approval in Europe to extend use of its t:slim X2 and Tandem Mobi automated insulin delivery systems to pregnancy in type 1 diabetes and adults with type 2 diabetes. This broader European certification opens access to new patient groups and care settings, potentially reinforcing Tandem’s role within integrated...

MongoDB (MDB) recently reported first quarter results and raised its full year 2027 revenue and earnings guidance, even as higher for longer interest rate expectations pressured growth stocks in broader trading. See our latest analysis for MongoDB. MongoDB's share price has been volatile recently, with a 7 day share price return down 12.71%, yet a 30 day share price return of 17.73% and a 90 day share price return of 30.31% hinting at rebuilding momentum despite a year to date share price...

Visteon Corporation recently announced that its 12.3-inch Narrow Border Driver Display is featured in the newly launched Lexus ES, marking a premium in-cabin technology application with an ultra-slim, high-brightness LCD panel and advanced optical bonding for improved clarity and reduced glare. This Lexus program also represents a manufacturing milestone for Visteon in Thailand, where full in-house display construction and optical bonding strengthen end-to-end production control across its...

Recent share performance and business scale Loma Negra Compañía Industrial Argentina Sociedad Anónima (LOMA) has seen its stock decline 14.7% year to date, while the past 3 months show a gain of 4.4% and the month is broadly flat. For context on the underlying business, the company reports revenue of roughly $850,476.19 and net income of about $36,113.48. Its operations span cement, concrete, aggregates, railway services and other related activities in Argentina. See our latest analysis for...

Why Hotel101 Global Holdings Stock Is Drawing Attention Now Hotel101 Global Holdings (NasdaqCM:HBNB) has been drawing attention after a period of weak share performance, with the stock down 8% over the past month and 33% over the past 3 months. For investors, the recent slide sits alongside a market value of about US$1.32b, revenue of US$75.87 million from property development, and a net loss of US$26.71 million. This combination is prompting a closer look at the business model. See our...

Alamo Group (ALG) has refreshed its funding setup with a Fourth Amended and Restated Credit Agreement, giving the company access to up to US$602.5m in term and revolving borrowings through 2031. See our latest analysis for Alamo Group. Despite this refreshed credit capacity, Alamo Group's recent share price return has been weak, with the stock down 11.6% year to date and the 1 year total shareholder return declining 27.5%. This indicates that momentum has faded even as financing flexibility...

Yesway (YSWY) is drawing attention after its recent share performance, with the stock down about 15% over the past month following a modest single-day and past-week decline. See our latest analysis for Yesway. That 14.6% decline in the 30 day share price return, alongside a small year to date share price gain of 3.7% with the stock now at US$22.01, suggests recent momentum has cooled after a firmer start to the year. If you are looking beyond Yesway and want ideas with a similar risk on...

ArcBest (ARCB) is catching investor attention after a strong run in the stock, with returns of 37.4% over the past month and 77.5% over the past 3 months, prompting closer scrutiny of fundamentals. See our latest analysis for ArcBest. At a share price of US$166.22, ArcBest’s recent gains have been rapid, with strong short term share price returns building on already solid multi year total shareholder returns. This may indicate shifting expectations around its growth prospects and risk...